Skip to main content
Previous Poster Home Next

Real-world clinical benefit among patients with lower-risk myelodysplastic syndromes treated with luspatercept
07:30am - 03:35pm EST - April 5, 2024

  • Information
  • Resources
  • Play Recording

Real-world clinical benefit among patients with lower-risk myelodysplastic syndromes treated with luspatercept icon

Abstract: JNCCN23-0620 https://jnccn.org/view/journal...


Author(s):
  • Kashyap Patel, MD, Minnesota Oncology
  • Derek Tang, PhD, MS, BSPharm, Health Outcomes Research Leader, Bristol-Myers Squibb

Tags: Outcomes and Health Services Research

Display Label Action
NCCN 2024 Patel poster_RW Outcomes with 1L Lusp_HR.pdf Download Handout
AC24P22 - Real-world clinical benefit among patients with lower-risk myelodysplastic syndromes treated with luspatercept Download MP3